Ovid Therapeutics Inc. — Form D
Ovid Therapeutics Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-20. The offering totals $25.9M, of which $25.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-01-20
- Form: D
- Accession: 0001636651-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $25.9M
- Amount sold: $25.9M
- Investors: 1
- Date of first sale: 2017-01-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278877
Issuer
- Name: Ovid Therapeutics Inc.
- CIK: 0001636651
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1460 Broadway, New York, NY, 10036
- Phone: 646-661-7661
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Karen E Bernstein | Director | New York, NY |
| Matthew J During | Director | New York, NY |
| Bart M Friedman | Director | New York, NY |
| Jeremy M Levin | Director | New York, NY |
| Douglas E Williams | Director | New York, NY |
| Matthew J During | Executive Officer | New York, NY |
| Jeremy M Levin | Executive Officer | New York, NY |
| Amit E Rakhit | Executive Officer | New York, NY |
| Yaron M Werber | Executive Officer | New York, NY |
| Mark M Feldberg | Director | New York, NY |
Other filings by this issuer (2)
More